M.R.A. Pillai Ph.D.; D.Sc Molecular Group of Companies, Cochin [email protected] https://independent.academia.edu/PillaiM RA Clinical Utilization of Re-188 Radiopharmaceuticals: Issues and solutions
M.R.A. Pillai Ph.D.; D.ScMolecular Group of Companies, Cochin
[email protected]://independent.academia.edu/PillaiMRA
Clinical Utilization of Re-188
Radiopharmaceuticals:Issues and solutions
177Lu and 90Y can be mass produced
Lutetium-177◦176Lu(n,g)177Lu
Specific activity >20 Ci/mgYttirum-90◦90Sr/90Y generator◦Large inventory of 90Sr◦Annual Production 600 Mega Curie
Production of long lived parent radionuclides for generators : 68Ge, 82Sr, 90Sr and 188W. (IAEA 2010)
Yttrium-90 Different technologies are available for the separation of 90Y from 90Sr
The electrochemical generator ‘Kamadhenu’ can provide a continuous source of 90Y from a single source of 90Sr
Current Status in India
90Y is not locally available 90Y microspheres for TARE can be imported at a cost of 0.6 million INR equivalent to ~ 10,000 USD
Thus the interest in 188Re as a cost effective alternative despite no local production of 188W or W/Re generator in India
188Re is a very useful till there is wider availability of 90Y.
There are three issues in the wider use of 188Re◦Availability of 188W◦Preparation of column generator◦Radiopharmaceuticals development
1. Production of 188W
Reactor production and processing of 188W. Knapp et al. 2010
Annual Production capacity 500-1000 CiEquivalent to 500-1000 generatorsSpecific activty 4-5 Ci/g
Issues with Column Generator Production 188W maximum specific activity is 4-5 Ci/g
Capacity of alumina for 188Re <50 mg/g2 g alumina can take ~ 400-500 mCi of activity
Generator with capacity >500 mCi will result in large elution volume.
Post elution concentration is an option; but a difficult option and not preferred
Nano crystalline Titania : 300 mg/g Nanocrystalline Zirconia : 325 mg/gNanocrystalline Alumina : 500 mg/g
Nano Alumina as column Matrix
1 g of nano-alumina generator can load >2 Ci of 188W
Low elution volume and high concentration eluent
Extended use of generator Nanoalumina based generator are acceptable to regulators
Radio-rheniums
185Re(n,g)186Re; s 114 barns187Re(n,g)188Re; s 72 barnsMultivalent and versatile chemistry
15
Mixed Radionuclide Therapy
A natural rhenium target when irradiated for 7 days reactor gives a mixture of 186Re and 188Re at ~40:60 ratio:
A day cooling will yield a mixture of 60:40.
Both the radionuclides are useful for therapy
3. Rhenium ChemistryTechnetium and rhenium has identical chemical properties
Hence most technetium complexes can be duplicated with rhenium
The above statements are true to some extent; but miserably fail once we start exploring
the chemistry
Products developed
186/188Re-HEDP186/188Re-CTMP186/188Re-DMSA(Sn)186/188Re-DMSA(MBS)186/188Re-HA particles186/188Re-EC
• Natural rhenium metal irradiated for 7 days; followed by 4 days cooling•Dissolution in HNO3, evaporation and addition of ammonia to convert to ammonium perrhenate, poor complexation •Extraction in MEK and dissolution in saline improves the complexation efficiency
186/188Re-HEDP50 mg HEDP10 mg SnCl2100 mg rhenium carrierPerrhenate (NaReO4)Complexation at pH 2, 100oCStorage upto 4 days at pH 2 and at 4oC
Adjusting the pH to 8 reduces the kidney dose
Bone uptake ~30% at 48 h p.i.
99mTc(V)DMSA for imaging medullary thyroid carcinoma
188Re(V)DMSA for treatment of medullary thyroid carcinoma
High renal uptake Metastatic bone pain palliation
ConclusionsThe limitations w.r.t 188W production and availability will continue
Nano-alumina based column generator will be advantageous
188Re-HEDP could be a readily available radiopharmaceutical for bone pain palliation.
188Re-CTMP might be better than 188Re-HEDP; and worth exploring
188Re-DMSA is useful for medullary thyroid carcinoma.
Depending upon the method of production; rhenium complexes could be different and hence need careful evaluation